WallStreetZenWallStreetZen

How to Buy Acumen Pharmaceuticals Stock

Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease.

Acumen Pharmaceuticals stock last closed at $2.64, down 2.22% from the previous day, and has decreased 55.18% in one year. It has underperformed other stocks in the Biotechnology industry by 0.32 percentage points. Acumen Pharmaceuticals stock is currently +45.86% from its 52-week low of $1.81, and -76.66% from its 52-week high of $11.31.

There are currently 60.08M shares of ABOS outstanding. The market cap of ABOS is $158.61M. In the past 24 hours, 399,492 ABOS shares were traded.

How to Buy Acumen Pharmaceuticals Stock

Wondering how to invest in Acumen Pharmaceuticals stock? Here's how.
  1. Figure out where to buy Acumen Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Acumen Pharmaceuticals stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Put funds into your brokerage account: Pick your payment method and add your details.
  4. Evaluate Acumen Pharmaceuticals stock: The Acumen Pharmaceuticals ticker symbol is ABOS. Is Acumen Pharmaceuticals stock a good investment? Should you buy shares of ABOS? How do ABOS's underlying business fundamentals look? Do top analysts think Acumen Pharmaceuticals is a good buy? Why has ABOS's stock price moved recently? (Hint: Our stock analysis website can help you figure out if ABOS is a good stock to buy).
  5. Place your ABOS trade: Decide if you will purchase ABOS shares at the current market price or use a limit order to purchase ABOS stock at a particular price.
  6. Get the latest scoop on your ABOS position: Create a watchlist to important updates regarding your new investment in Acumen Pharmaceuticals stock.

Step 1: Figure out where to buy Acumen Pharmaceuticals stock

You will need a brokerage account to access the NASDAQ market and buy ABOS shares.

A brokerage account enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've selected the best brokerage, you'll need to fill out some personal information so you are able to invest in ABOS stock today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open your new brokerage account.
  1. Send your details by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have created your account on the best stock app to use, you need to deposit funds:

Check out the walkthrough below to see the process of transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Acumen Pharmaceuticals stock

After you have identified the best place to buy Acumen Pharmaceuticals stock, it's absolutely critical to analyze their stock before you invest, so you truly wrap your head around the risk and upside.

Acumen Pharmaceuticals shares at a glance

ABOS Price
$2.64
1w %
6.02%
1y %
-55.18%
5y %
N/A
P/E
-2.49x
P/B
0.61x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$55.94M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$158.61M
Next Earnings
Aug 8, 2024
Next Dividend
N/A

ABOS Zen Score

WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.

You can see all of the due diligence checks on ABOS's stock page.

What is the fair value of ABOS stock?

Investors use many financial metrics, analyses, models, and charts to gauge ABOS's true value.

Using relative valuations metrics:

  • ABOS may be undervalued based on its P/B ratio of 0.61x, relative to Biotechnology industry P/B ratio of 6.3x

You can do additional valuation research on ABOS's stock here.

A look at ABOS Cashflows and Balance Sheet

Pros:

  • ABOS has cash burn of 50777000. It has sufficient cash and short-term investments to cover this for at least one year.
  • ABOS has $252.75M in cash and short term investments. This is sufficient to cover its annual cash burn of $50.78M.
  • ABOS has a low debt to equity ratio of 0.15.
  • There are more short-term assets than long-term liabilities on the ABOS balance sheet.
  • There are more short-term assets than short-term liabilities on the ABOS balance sheet.

Is Acumen Pharmaceuticals stock a Buy, Hold, or Sell, according to analysts?

Out of 1 Wall Street analysts who give recommendations on ABOS, the consensus analyst rating on ABOS is a Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are projecting on the Acumen Pharmaceuticals stock forecast page.

ABOS Technical Indicators

SMA10
1.1
SMA20
1.1
SMA50
1.14
SMA100
1.22
SMA200
1.44
MACD
-0.01
MACD Signal
-0.01
MACD Histogram
0.01
RSI
47.92
Stochastic %K
75.28
Stochastic %D
78.07
StochRSI %K
77.78
StochRSI %D
87.66

Are ABOS insiders buying or selling the stock?

In the last 12 months, insiders at ABOS have bought more shares than they have sold.

Derek M. Meisner, Chief Legal Officer Corp Sec of ABOS, was the latest ABOS insider to sell. They sold $31,051.11 worth of ABOS stock on Jan 19, 2024.

Learn more about who owns ABOS shares here.

Can I rely on ABOS as an income stream?

No, Acumen Pharmaceuticals doesn't provide an income stream by paying out dividends.

ABOS Social Trading Data

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Place your ABOS trade

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly the best for newer investors.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a particular dollar amount, place a limit order.

Hit the Open button and your broker will place your order.

If you want additional help investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest scoop on your ABOS position

Now that you own some shares in ABOS, you'll want to keep up with your new shares.

Add ABOS to a watchlist to keep track of your ABOS stock.

ABOS Feed

How to Buy Stock in Acumen Pharmaceuticals

To reiterate, here are the 6 steps to buy stock in Acumen Pharmaceuticals:

  1. Figure out where to buy Acumen Pharmaceuticals stock
  2. Sign up for your brokerage account
  3. Put funds into your brokerage account
  4. Evaluate Acumen Pharmaceuticals stock
  5. Place your ABOS trade
  6. Get the latest scoop on your ABOS position

If you require a brokerage account, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to track your new investment in Acumen Pharmaceuticals, click the button below.

NASDAQ: ABOS
$2.64-0.06 (-2.22%)
Updated Jun 13, 2024
Open eToro Account
NASDAQ: ABOS
$2.64-0.06 (-2.22%)
Updated Jun 13, 2024
Open eToro Account

FAQ

How much does it cost to buy one Acumen Pharmaceuticals share?

As of Jun 13, 2024, it costs $2.64 to buy one share of Acumen Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.379 shares of ABOS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Acumen Pharmaceuticals stock?

According to 1 Wall Street analysts who monitor Acumen Pharmaceuticals, their consensus recommendation is to buy Acumen Pharmaceuticals stock.

What is the best way to buy Acumen Pharmaceuticals stock?

One way to place an order for Acumen Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.